These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 23173289)
1. [Diagnosis and treatment of hepatitis C]. Thies P; Schmid RM; Geisler F MMW Fortschr Med; 2012 Nov; 154(19):59-62. PubMed ID: 23173289 [No Abstract] [Full Text] [Related]
2. Hepatitis C virus: the burden of the disease. Adler M; Goubau P; Nevens F; Van Vlierberghe H Acta Gastroenterol Belg; 2002; 65(2):83-6. PubMed ID: 12148444 [TBL] [Abstract][Full Text] [Related]
3. Prevalence and challenges of liver diseases in patients with chronic hepatitis C virus infection. Jacobson IM; Davis GL; El-Serag H; Negro F; Trépo C Clin Gastroenterol Hepatol; 2010 Nov; 8(11):924-33; quiz e117. PubMed ID: 20713178 [TBL] [Abstract][Full Text] [Related]
5. British HIV Association guidelines for the management of coinfection with HIV-1 and hepatitis B or C virus 2010. Brook G; Main J; Nelson M; Bhagani S; Wilkins E; Leen C; Fisher M; Gilleece Y; Gilson R; Freedman A; Kulasegaram R; Agarwal K; Sabin C; Deacon-Adams C; HIV Med; 2010 Jan; 11(1):1-30. PubMed ID: 20059574 [No Abstract] [Full Text] [Related]
6. Hepatocellular carcinoma: an emerging problem with hepatitis C. Jeffers L J Natl Med Assoc; 2000 Aug; 92(8):369-71. PubMed ID: 10992680 [TBL] [Abstract][Full Text] [Related]
7. The natural history of hepatitis C viral infection. Muir AJ Semin Gastrointest Dis; 2000 Apr; 11(2):54-61. PubMed ID: 10803630 [TBL] [Abstract][Full Text] [Related]
8. Profile and value of FIB-4 in patients with dual chronic hepatitis C and B. Liu CJ; Tseng TC; Yang WT; Su TH; Yang HC; Liu CH; Chen PJ; Chen DS; Kao JH J Gastroenterol Hepatol; 2019 Feb; 34(2):410-417. PubMed ID: 30151861 [TBL] [Abstract][Full Text] [Related]
9. The socioeconomic impact of hepatitis C infection and liver transplantation in Mexico. Méndez-Sánchez N Ann Hepatol; 2012; 11(4):550-1. PubMed ID: 22700637 [No Abstract] [Full Text] [Related]
10. Data to guide the "test and treat era" of hepatitis C. Ward JW; Rein DB; Smith BD Gastroenterology; 2012 Oct; 143(4):887-9. PubMed ID: 22922026 [No Abstract] [Full Text] [Related]
11. Treatment of HBV related cirrhosis. van Bömmel F; Berg T Liver Int; 2013 Feb; 33 Suppl 1():176-81. PubMed ID: 23286862 [TBL] [Abstract][Full Text] [Related]
12. Editorial - HCC in HCV patients and the direct acting antivirals: is there really a link? Marrone A; Franci G; Perrella A; Nevola R; Chianese A; Adinolfi LE; Sasso FC; Rinaldi L Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):983-987. PubMed ID: 32017007 [No Abstract] [Full Text] [Related]
14. Hepatocellular Carcinoma Risk Declines but Remains High Enough for Screening in the First 7 Years After Hepatitis C Virus Cure With Direct-Acting Antivirals in Patients With Cirrhosis or High Fibrosis-4 Score. Kim NJ; Vutien P; Berry K; Ioannou GN Gastroenterology; 2022 Oct; 163(4):1104-1106.e3. PubMed ID: 35777481 [No Abstract] [Full Text] [Related]
15. [Incidence of hepatocellular carcinoma and consequent lessons for its management in Northeastern Hungary]. Papp R; Papp M; Tornai I; Vitális Z Orv Hetil; 2016 Nov; 157(45):1793-1801. PubMed ID: 27817236 [TBL] [Abstract][Full Text] [Related]
16. Predicted effects of treatment for HCV infection vary among European countries. Deuffic-Burban S; Deltenre P; Buti M; Stroffolini T; Parkes J; Mühlberger N; Siebert U; Moreno C; Hatzakis A; Rosenberg W; Zeuzem S; Mathurin P Gastroenterology; 2012 Oct; 143(4):974-85.e14. PubMed ID: 22863764 [TBL] [Abstract][Full Text] [Related]